||5R01CA242929-04 Interpret this number
||University Of Chicago
||Transcriptome-Wide Association Studies and Genetic Risk Prediction for Breast Cancer Integrating Rna Splicing and Gene Expression From Multiple Tissues
Breast cancer is the most common cancer in women in the United States and worldwide. Although
genome-wide association studies have identified multiple loci for breast cancer, most of heritability is still
hidden. To date, transcriptome-wide association studies (TWAS) have been performed to quantify
associations of genetically predicted gene expression with breast cancer risk. Our recent work showed
that genetic variants that affect RNA splicing are very important contributors to complex traits but were
previously missed when considering the genetic effects on gene expression only. Therefore, evaluating
associations of genetically predicted splicing (as a linear combination of SNPs) with phenotypes has a
great promise to discover novel putative candidate disease genes. Splicing events in local regions (such
as intron excision clusters) can be highly correlated. However, existing statistical methods for TWAS do
not account for correlation among splicing events, and thus may result in loss of power in detecting
disease genes. Additionally, splicing levels (quantified as relative count ratios) in a gene and the overall
gene expression level have not been considered together in previous gene mapping methods. For breast
cancer prevention, stratification of women according to the risk of developing the cancer could improve
risk reduction and screening strategies by targeting those most likely to benefit. SNP-based polygenic
risk scores have been developed to predict breast cancer but their prediction accuracy remains low. To
increase prediction accuracy, there is a need to incorporate useful information from genetically predicted
expression and splicing. Recently, several transcriptome studies, such as GTEx, have collected DNA
and RNA from multiple tissue samples; integrating information across multiple tissues into TWAS could
significantly improve the identification of disease genes. In addition, African Americans (AAs) have
different linkage disequilibrium (LD) pattern from Europeans, so genetic variants that affect RNA splicing
and disease phenotypes could be ethnicity-specific. The objective of this study is to develop effective
methods for gene mapping and genetic risk prediction of complex traits such as breast cancer by
integrating multi–omics data from multiple tissues. Specifically, we will 1) develop methods for TWAS
that leverage information of RNA splicing and expression from multiple tissues and apply the methods to
identify novel breast cancer susceptibility genes; 2) develop joint polygenic risk prediction scores for
breast cancer that model different LD patterns in distinct populations (including AAs) and incorporate
information of genetically predicted splicing and gene expression from multiple tissues. We will account
for correlation among splicing events in local regions and across multiple tissues. We expect that the
proposed methods have higher power in gene mapping or higher accuracy in prediction of breast cancer
than existing methods. The proposed methods can also be applied to other complex diseases.
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.
, Zhao F.
, Ahearn T.U.
, Lunetta K.L.
, Troester M.A.
, Du Z.
, Ogundiran T.O.
, Ojengbede O.
, Blot W.
, Nathanson K.L.
, et al.
Human molecular genetics, 2022-09-10; 31(18), p. 3133-3143.
Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries.
, Pividori M.
, Manichaikul A.
, Palmer A.A.
, Cox N.J.
, Wheeler H.E.
, Im H.K.
Genome biology, 2022-01-13; 23(1), p. 23.
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.
, Du Z.
, Gao G.
, Ahearn T.U.
, Lunetta K.L.
, Zirpoli G.
, Figueroa J.
, John E.M.
, Bernstein L.
, Zheng W.
, et al.
Nature communications, 2021-07-07; 12(1), p. 4198.
The impact of cell type and context-dependent regulatory variants on human immune traits.
, Wei W.
, Fair B.
, Miao J.
, Zhu P.
, Li Y.I.
Genome biology, 2021-04-29; 22(1), p. 122.
Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.
, Huo D.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020 Nov; 29(11), p. 2332-2342.